A detailed history of Washington Trust Advisors, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 769 shares of GILD stock, worth $67,733. This represents 0.0% of its overall portfolio holdings.

Number of Shares
769
Previous 876 12.21%
Holding current value
$67,733
Previous $64,000 18.75%
% of portfolio
0.0%
Previous 0.01%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$63.15 - $72.88 $6,757 - $7,798
-107 Reduced 12.21%
769 $52,000
Q4 2023

Jan 18, 2024

BUY
$73.27 - $83.09 $805 - $913
11 Added 1.27%
876 $70,000
Q3 2023

Oct 18, 2023

BUY
$73.94 - $80.67 $4,288 - $4,678
58 Added 7.19%
865 $64,000
Q2 2023

Jul 27, 2023

SELL
$76.01 - $86.7 $18,090 - $20,634
-238 Reduced 22.78%
807 $62,000
Q1 2023

May 04, 2023

SELL
$77.31 - $88.08 $2,010 - $2,290
-26 Reduced 2.43%
1,045 $86,000
Q4 2022

Feb 08, 2023

SELL
$62.32 - $89.47 $747 - $1,073
-12 Reduced 1.11%
1,071 $91,000
Q3 2022

Oct 14, 2022

BUY
$59.54 - $68.01 $2,202 - $2,516
37 Added 3.54%
1,083 $67,000
Q2 2022

Jul 25, 2022

SELL
$57.72 - $65.01 $18,470 - $20,803
-320 Reduced 23.43%
1,046 $65,000
Q1 2022

May 05, 2022

SELL
$57.92 - $72.58 $1,100 - $1,379
-19 Reduced 1.37%
1,366 $81,000
Q4 2021

Feb 11, 2022

BUY
$64.88 - $73.64 $89,858 - $101,991
1,385 New
1,385 $101,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Washington Trust Advisors, Inc. Portfolio

Follow Washington Trust Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Advisors, Inc. with notifications on news.